Clinical trials
Completed Observational Kidney Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
101 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 6 |
| 2008 | 5 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 9 |
| 2013 | 3 |
| 2014 | 8 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 8 |
| 2021 | 7 |
| 2022 | 6 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 101 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 11 |
| Pfizer | 6 |
| Bristol-Myers Squibb | 4 |
| Samsun Liv Hospital | 3 |
| University Hospital, Bordeaux | 3 |
| Central Hospital, Nancy, France | 2 |
| Centre Hospitalier Universitaire de Nice | 2 |
| GlaxoSmithKline | 2 |
| National Cancer Institute (NCI) | 2 |
| Peking University First Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Neoplasms | 101 |
| Carcinoma, Renal Cell | 36 |
| Prostatic Neoplasms | 16 |
| Lung Neoplasms | 13 |
| Urinary Bladder Neoplasms | 12 |
| Neoplasms | 11 |
| Pancreatic Neoplasms | 11 |
| Stomach Neoplasms | 9 |
| Breast Neoplasms | 8 |
| Wilms Tumor | 8 |
Trials
Showing 1 to 25 of 101. Each trial links to its page on Pharma Observatory.
1 more trial matches. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.